Epidemiology of the influenza a virus H5N1 subtype and memory of immunity to the H2N2 subtype

mBio

Volumn 3, Issue 4, 2012, Pages

  Terajima, Masanori ^a   Babon, Jenny Aurielle B ^a   Ennis, Francis A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ANTIGEN BINDING; CROSS REACTION; HUMAN; IMMUNOLOGICAL MEMORY; INFLUENZA A (H2N2); INFLUENZA A (H5N1); LETTER; PANDEMIC; PHYLOGENY; PRIORITY JOURNAL; VACCINATION; VIRAL GENETICS; VIRUS IMMUNITY; VIRUS NEUTRALIZATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS TYPING; WORLD HEALTH ORGANIZATION;

INFLUENZA A VIRUS;

EID: 84865729727     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00138-12     Document Type: Letter

References (15)

1. Palese P, Wang TT. 2011. Why do influenza virus subtypes die out? A hypothesis. mBio 2(5):e00150-11. http://dx.doi.org/10.1128/mBio.00150-11
2. Pica N, et al. 2012. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc. Natl. Acad. Sci. U. S. A. 109:2573-2578.
3. World Health Organization. 2006. Epidemiology of WHO-confirmed human cases of avian influenza A(H5N1) infection. Wkly. Epidemiol. Rec. 81:249-257.
4. Smallman-Raynor M, Cliff AD. 2007. Avian influenza A (H5N1) age distribution in humans. Emerg. Infect. Dis. 13:510-512.
5. Dowdle WR. 1999. Influenza A virus recycling revisited. Bull. World Health Organ. 77:820-828.
6. Russell RJ, et al. 2008. Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion. Proc. Natl. Acad. Sci. U. S. A. 105:17736-17741.
7. Fouchier RA, et al. 2005. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 79:2814-2822.
8. Suzuki Y, Nei M. 2002. Origin and evolution of influenza virus hemagglutinin genes. Mol. Biol. Evol. 19:501-509.
9. Clementi N, et al. 2011. A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes. PLoS One 6:e28001. http://dx.doi.org/10.1371/journal.pone.0028001
10. Corti D, et al. 2011. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333:850-856.
11. Wang TT, et al. 2010. Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc. Natl. Acad. Sci. U. S. A. 107:18979-18984.
12. Li GM, et al. 2012. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc. Natl. Acad. Sci. U. S. A. 109:9047-9052.
13. Thomson CA, et al. 2012. Pandemic H1N1 influenza infection and vaccination in humans induces Cross-protective antibodies that target the hemagglutinin stem. Front. Immunol. 3:87.
14. Xu W, Han L, Lin Z. 2011. Screening of random peptide library of hemagglutinin from pandemic 2009 A(H1N1) influenza virus reveals unexpected antigenically important regions. PLoS One 6:e18016. http://dx.doi.org/10.1371/journal.pone.0018016
15. Corti D, et al. 2010. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J. Clin. Invest. 120:1663-1673.